Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer

• Published in: Journal for immunotherapy of cancer Vol. 9; no. 3; p. e001610
• Main Authors: Seo, Incheol, Lee, Hye Won, Byun, Sang Jun, Park, Jee Young, Min, Hyeonji, Lee, Sung Hwan, Lee, Ju-Seog, Kim, Shin, Bae, Sung Uk
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 01.03.2021; BMJ Publishing Group
• Series: Original research
• Subjects: Adenocarcinoma - genetics; Adenocarcinoma - immunology; Adenocarcinoma - pathology; Adenocarcinoma - therapy; Bioinformatics; Biomarkers; Biomarkers, Tumor - genetics; Biopsy; Cancer; Cancer therapies; Chemoradiotherapy, Adjuvant; Colorectal cancer; Databases, Genetic; Encyclopedias; Gene expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genomes; HCT116 Cells; Humans; Immunotherapy; Immunotherapy Biomarkers; Neoadjuvant Therapy; Principal components analysis; Quality control; Radiation therapy; Rectal Neoplasms - genetics; Rectal Neoplasms - immunology; Rectal Neoplasms - pathology; Rectal Neoplasms - therapy; RNA-Seq; Time Factors; Transcriptome; Treatment Outcome; Tumor Microenvironment - immunology; United States > US; Maryland; California; radiotherapy; immunomodulation; radioimmunotherapy; genome instability; gene expression profiling
• ISSN: 2051-1426; 2051-1426
• DOI: 10.1136/jitc-2020-001610

BackgroundNeoadjuvant chemoradiation therapy (CRT) is a widely used preoperative treatment strategy for locally advanced rectal cancer (LARC). However, a few studies have evaluated the molecular changes caused by neoadjuvant CRT in these cancer tissues. Here, we aimed to investigate changes in immunotherapy-related immunogenic effects in response to preoperative CRT in LARC.MethodsWe analyzed 60 pairs of human LARC tissues before and after irradiation from three independent LARC cohorts, including a LARC patient RNA sequencing (RNA-seq) dataset from our cohort and GSE15781 and GSE94104 datasets.ResultsGene ontology analysis showed that preoperative CRT significantly enriched the immune response in LARC tissues. Moreover, gene set enrichment analysis revealed six significantly enriched Kyoto Encyclopedia of Genes and Genomes pathways associated with downregulated genes, including mismatch repair (MMR) genes, in LARC tissues after CRT in all three cohorts. Radiation also induced apoptosis and downregulated various MMR system-related genes in three colorectal cancer cells. One patient with LARC showed a change in microsatellite instability (MSI) status after CRT, as demonstrated by the loss of MMR protein and PCR for MSI. Moreover, CRT significantly increased tumor mutational burden in LARC tissues. CIBERSORT analysis revealed that the proportions of M2 macrophages and CD8 T cells were significantly increased after CRT in both the RNA-seq dataset and GSE94104. Notably, preoperative CRT increased various immune biomarker scores, such as the interferon-γ signature, the cytolytic activity and the immune signature.ConclusionsTaken together, our findings demonstrated that neoadjuvant CRT modulated the immune-related characteristics of LARC, suggesting that neoadjuvant CRT may enhance the responsiveness of LARC to immunotherapy.